Molgramostim biosimilar (RAS Lifesciences)

莫拉司亭生物类似药 (RAS Lifesciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim biosimilar (RAS Lifesciences)
Drug Alias Name莫拉司亭生物仿制药 (RAS Lifesciences)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/10/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiomerieux
China Registration ClassN/A

Develop Information

Active CompaniesBiomerieux
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA03
Related LinksN/A